IRVING, Texas, March 8, 2011 /PRNewswire/ — (RBC Life Sciences:
OTC Bulletin Board:
RBCL) — RBC Life Sciences, Inc., a provider of proprietary
nutritional supplements, wound care and pain management products,
today reported a 13% increase in consolidated net sales to $28.2
million for the year ended December 31, 2010, compared to net sales
of $24.9 million for the same period during 2009. For 2010, the
Company reported net earnings of $558,000, or $0.02 per diluted
share, compared to a net loss of $335,000, or $0.02 per diluted
share, during 2009.
“We significantly improved our financial performance in 2010
reporting sales growth in both our Nutritional Products segment and
Medical Products segment,” said RBC Life Sciences President and
CEO, Clinton H. Howard. “We were particularly pleased to
report sales growth of 22% to our international licensees, which is
our largest revenue channel. This growth in sales along with
expense reductions affected during 2010 resulted in an $893,000
improvement in net operating results and a return to profitability
in 2010.”
During 2010, net sales of Nutritional Products increased 15% to
$21.6 million while net sales of Medical Products increased 6% to
$6.5 million.
About RBC Life SciencesThrough wholly owned subsidiaries, RBC
Life Sciences develops, manufactures and markets high-quality
nutritional supplements and personal care products under its RBC
Life brand to a growing population of consumers seeking wellness
and a healthy lifestyle. Through its wholly owned subsidiary, MPM
Medical, the Company also develops and markets to health care
professionals in the United States proprietary prescription and
nonprescription products for advanced wound care and pain
management. All products are tested for quality assurance in-house,
and by outside independent laboratories, to comply with regulations
in the U.S. and in
‘/>”/>
SOURCE
